跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Approved
STANDARD
IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Samsung Bioepis Nl B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2022
Approval ID
b186b7e17f7539ca
Company
Samsung Bioepis Nl B.V.
Type
Standard
Approval Details
Approval Id
b186b7e17f7539ca
Drug Cima Aemps Name
IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number
1171216014
Holder Company Name
Samsung Bioepis Nl B.V.
Marketing Company Name
Biogen Spain S.L.
Holder Company Detail Path
/organization/samsung-bioepis-nl-b-v
Authorization Date
2022-07-21
Dosage Form
SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA
Dose
40 MG
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Samsung Bioepis Nl B.V.
Company Detail Path
/organization/samsung-bioepis-nl-b-v
Company Information
Pharmaceutical Company Name
Samsung Bioepis NL B.V.
Country Name
Netherlands
Active Ingredients
ADALIMUMAB
40 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2022
Approval ID
b186b7e17f7539ca
Type
Standard
Back to CIMA-AEMPS Approvals
